People with chronic primary pain should be offered a range of treatments to help them manage their condition, says NICE in a new guideline.

PLASMA offers lower risk of serious complications, and shorter hospital stay and cost savings to NHS.

Local health commissioners should consider promoting community pharmacies as a first port of call for health and wellbeing, NICE has said. 

Several commonly used treatments for chronic primary pain have little or no evidence that they work and shouldn’t be prescribed, NICE says in new draft guidance

Rezum recommended as a treatment option for moderate to severe lower urinary tract symptoms.

The Commission on Human Medicines has said patients can take paracetamol or ibuprofen when self-medicating for symptoms of Covid-19.

Fremanezumab now available on the NHS in England and Wales for up to 10,000 people.

Digital tools should be offered in addition to existing health services, not as a replacement, says NICE

NICE is calling for the NHS to make greater use of community pharmacies to promote health and wellbeing in local areas.

Doctors can prescribe Epidyolex with clobazam, a seizure-preventing cannabis-based treatment.

PHE is collaborating with the Scottish, Welsh and Northern Ireland governments to produce the first UK-wide clinical guidelines for alcohol misuse.

European authorities have for the first time approved a cannabis-based medicine for use in severe childhood epilepsy.

A handheld device that delivers a small electric current has been recommended in draft guidance by NICE.

The new recommendations reduce the CVD risk threshold at which treatment for hypertension should be considered.

Sir Andrew Dillon has announced his intention to stand down as chief executive at the National Institute for Health and Care Excellence (NICE).

NICE has decided not to recommend the use of cannabis-based medicines in severe treatment-resistant epilepsy.

e number of people suffering with the tick-borne infection may be about three times higher than the official estimate.

Pharmacists in all settings should be integrated into services aimed at preventing and managing type 2 diabetes.

Metered dose inhalers, containing hydrofluorocarbons, have estimated carbon footprints of 500g CO2eq per dose, compared to 20g in dry powder inhalers

The NHS across the UK is expected to save around £930m on its medicine bill under a new scheme